Pelagos Insurance Capital Ltd operates in the specialty insurance and reinsurance sector. Its activities include capital allocation, risk selection, and the deployment of capital through underwriting partnerships across insurance and reinsurance markets. The company manages a diversified portfolio and works with underwriting partners to provide insurance and reinsurance solutions to clients and brokers.
Last trade$28.28
Day change-$0.51 (-1.77%)
Day range$28.13 – $28.75
Volume157,958
Market cap$2.28B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for PLGO.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for PLGO.
Recent news
Company coverage with links to the original publishers.
Pelagos Insurance Capital reported Q3 earnings of $1 per share, beating consensus estimates of $0.79, with a 26.58% earnings surprise. Revenues reached $828.3 million, surpassing estimates by 15.23%. However, the stock received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends ahead of the earnings release. The company has outperformed the S&P 500 by 44.8% year-to-date, but faces headwinds from its industry ranking in the bottom 42% of Zacks industries.
Octave Specialty Group (OSG) reported a quarterly loss of $0.03 per share, beating the consensus estimate of $0.06 loss by 50%, though the company has significantly underperformed the S&P 500 this year, declining 35.9% versus the market's 7.8% gain. The stock holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions, while the Insurance - Multi line industry ranks in the bottom 35% of sectors.
Oscar Health (OSCR) reported quarterly earnings of $0.49 per share, significantly beating the consensus estimate of a loss of $0.11 per share, with a 545% earnings surprise. The company posted revenues of $5.14 billion, surpassing estimates by 8.84% and more than doubling year-ago revenues of $2.99 billion. The stock has gained 144.9% year-to-date and received a Zacks Rank #1 (Strong Buy) rating, though the broader Insurance - Multi line industry ranks in the bottom 36% of industries.
Pelagos Insurance Capital (PLGO) is expected to report a 34.7% year-over-year decline in earnings for Q3 2026 despite 11.3% revenue growth. With an Earnings ESP of 0% and a Zacks Rank of #4, the stock is not considered a compelling earnings-beat candidate. The company has a poor recent surprise history, missing estimates by 61.36% in the last quarter.
Markel Group reported Q3 2026 earnings of $35.07 per share, beating consensus estimates by 25.56%, with revenues of $4.16 billion exceeding expectations by 3.80%. However, the stock has declined 13.5% year-to-date versus the S&P 500's 12.8% gain. The company holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions, and operates in the Insurance - Multi line industry which ranks in the bottom 30% of Zacks industries.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.22 per share
Declared
Nov 3, 2026
Ex-dividend
Dec 11, 2026
Pay date
Dec 23, 2026
Ex-dividend
Amount / share
Pay date
Type
Sep 14, 2026
$0.15
Sep 25, 2026
recurring
Jun 15, 2026
$0.15
Jun 26, 2026
recurring
Stock splits
Historical share-structure events and their execution dates.